Opportunity
SAM #75N98026Q01123
NIH Solicitation for In Vivo Efficacy Testing of Blood-Stable Thiobenzamides
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
September 10, 2026
Respond By
September 20, 2026
Identifier
75N98026Q01123
NAICS
541715, 541714, 541380, 325414
This opportunity from the National Institutes of Health (NIH) Office of Acquisitions seeks commercial services for evaluating the efficacy of blood-stable thiobenzamides in vivo. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Acquisitions - No specific OEMs or commercial vendors are named; the procurement is for specialized laboratory services. - Services Requested: - Mouse and disease model induction and treatment (20 units) - Viral load monitoring in BSL-3 environment (20 units) - Sample collection (20 units) - Immunophenotyping on blood samples (20 units) - Immunophenotyping following ex vivo stimulation (20 units) - Project management and updates (1 unit) - Standard report (1 unit) - Unique/Notable Requirements: - Services must include animal models, high-containment viral monitoring, and advanced immunophenotyping - Project management and reporting are integral to the contract - NAICS code 325414 (Biological Product (except Diagnostic) Manufacturing) - Not set aside for small businesses
Description
COMBINED SYNOPSIS / SOLICITATION
See attached
Solicitation No.: 75N98026Q01123